Type II or Type III Osteogenesis imperfecta
Showing 1 - 25 of >10,000
Osteogenesis Imperfecta, Osteogenesis Imperfecta Type III Trial (Bone marrow-derived mesenchymal stromal cells (MSCs))
Not yet recruiting
- Osteogenesis Imperfecta
- Osteogenesis Imperfecta Type III
- Bone marrow-derived mesenchymal stromal cells (MSCs)
- (no location specified)
Nov 28, 2022
Osteogenesis Imperfecta Trial in Albuquerque (Setrusumab)
Recruiting
- Osteogenesis Imperfecta
- Setrusumab
-
Albuquerque, New MexicoNew Mexico Clinical Research & Osteoporosis Center
Jul 29, 2022
Osteogenesis Imperfecta, Type I, Osteogenesis Imperfecta Type III, Osteogenesis Imperfecta Type IV Trial in Worldwide
Completed
- Osteogenesis Imperfecta, Type I
- +2 more
- setrusumab
- +3 more
-
Birmingham, Alabama
- +24 more
Feb 7, 2022
Cesarean Section, Quadratus Lumborum Block, Transversus Abdominis Plane Block Trial in Cairo (Quadratus lumborum block typen II,
Completed
- Cesarean Section
- +2 more
- Quadratus lumborum block typen II
- +2 more
-
Cairo, EgyptThe General Authority for Teaching Hospitals and Institutes
Jul 22, 2023
Dental Implant Trial (Type I Dental implant placement., Type II Dental implant placement., Type III/IV dental implant
Not yet recruiting
- Dental Implant
- Type I Dental implant placement.
- +2 more
- (no location specified)
Aug 4, 2023
Osteogenesis Imperfecta Trial in Los Angeles, Bethesda, Kansas City (Invisalign)
Recruiting
- Osteogenesis Imperfecta
- Invisalign
-
Los Angeles, California
- +2 more
Sep 19, 2022
Mucopolysaccharidosis III-A Trial in Hamburg (JR-441)
Recruiting
- Mucopolysaccharidosis III-A
-
Hamburg, GermanyUniversitätsklinikum Hamburg-Eppendorf
Oct 18, 2023
Children and Young Adults With Osteogenesis Imperfecta
Recruiting
- Osteogenesis Imperfecta
- Vestibular Assessment
- +2 more
-
Paris, FranceHôpital Necker-Enfants Malades
Jan 3, 2023
Type 2 Diabetes Trial in Hortolândia (LID104, Dapagliflozin, Linagliptin)
Not yet recruiting
- Type 2 Diabetes Mellitus
- LID104
- +2 more
-
Hortolândia, SP, BrazilInvestigational site
May 23, 2023
Spinal Cord Gray Matter Imaging in Spinal Muscular Atrophy
Enrolling by invitation
- Spinal Muscular Atrophy Type III
- Spinal Muscular Atrophy Type II
- MRI
-
Basel, BS, SwitzerlandUniversity Hospital Basel
Nov 15, 2023
Diabetes, Type 2 Trial (NW Low-Glu®, Metformin)
Not yet recruiting
- Diabetes Mellitus, Type 2
- NW Low-Glu®
- Metformin
- (no location specified)
Nov 20, 2023
Vulvar Diseases, HPV Infection, Vulvar HSIL Trial in Cleveland, Mayfield Heights (Artesunate ointment, Placebo ointment)
Not yet recruiting
- Vulvar Diseases
- +12 more
- Artesunate ointment
- Placebo ointment
-
Cleveland, Ohio
- +2 more
Oct 4, 2023
Hypertension Associated, Type II Diabetes Trial (Egito, Empagliflozin + telmisartan)
Not yet recruiting
- Hypertension Associated
- Type II Diabetes Mellitus
- Egito
- Empagliflozin + telmisartan
- (no location specified)
Aug 3, 2022
Type 1 Diabetes Trial in Toronto, Vancouver (Ustekinumab, Placebo)
Recruiting
- Type 1 Diabetes Mellitus
- Ustekinumab
- Placebo
-
Toronto, British Columbia, Canada
- +1 more
Jun 3, 2022
Breast Cancer, Stage 0, Colorectal Cancer Stage I, Head Neck Cancer Stage I Trial (CaRE@Home intervention)
Not yet recruiting
- Breast Cancer, Stage 0
- +11 more
- CaRE@Home intervention
- (no location specified)
Jun 9, 2023
Laryngeal Cancer, Dysphagia Trial in Guangzhou (Open partial horizontal laryngectomy(OPHL), Type I-III, Transoral endoscopic
Recruiting
- Laryngeal Cancer
- Dysphagia
- Open partial horizontal laryngectomy(OPHL), Type I-III
- Transoral endoscopic laser cordectomy
-
Guangzhou, Guangdong, ChinaGuangdong Provincial People's hospital
Sep 8, 2023
Type 2 Diabetes, Dyslipidemia Trial (BERLIM 25/10 association, EMPAGLIFLOZIN, ROSUVASTATIN CALCIUM)
Not yet recruiting
- Type 2 Diabetes Mellitus
- Dyslipidemia
- BERLIM 25/10 association
- +5 more
- (no location specified)
Aug 3, 2022
Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II Trial (PHA-022121 low dose, PHA-022121 medium
Recruiting
- Hereditary Angioedema
- +11 more
- PHA-022121 low dose
- +3 more
-
Birmingham, Alabama
- +7 more
Dec 5, 2022
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Germany (5-Fluorouracil, Leucovorin, Oxaliplatin)
Recruiting
- Gastric Cancer
- Gastroesophageal Junction Adenocarcinoma
- 5-Fluorouracil
- +4 more
-
Aachen, Germany
- +14 more
Sep 7, 2022
Anaplastic Astrocytoma, IDH-Wildtype, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Houston (other,
Recruiting
- Anaplastic Astrocytoma, IDH-Wildtype
- +8 more
- Quality-of-Life Assessment
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Dec 8, 2022
Hypertension Associated, Type II Diabetes Trial (Atenas, Atenas )
Not yet recruiting
- Hypertension Associated
- Type II Diabetes Mellitus
- Atenas
- Atenas placebo
- (no location specified)
Dec 15, 2021
Cardiopulmonary Outcomes in Osteogenesis Imperfecta: BBD7708
Recruiting
- Osteogenesis Imperfecta
-
Los Angeles, California
- +2 more
Sep 19, 2022
Osteogenesis Imperfecta Trial in Toulouse (Adapted Physical Activity program)
Not yet recruiting
- Osteogenesis Imperfecta
- Adapted Physical Activity program
-
Toulouse, FranceCHU Toulouse
Jun 27, 2023
Results of Telescoping Nail In OI; a Case Series
Recruiting
- Osteogenesis Imperfecta
- telescoping intramedullary nail
-
Assiut, EgyptAssiut University Hospital AUH
Aug 28, 2021
Intervention for the Effects of Osteogenesis Imperfecta
Completed
- Osteogenesis Imperfecta
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023